SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-019278
Filing Date
2020-04-28
Accepted
2020-04-28 16:56:54
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20200331.htm   iXBRL 10-Q 1361727
2 EX-31.1 crsp-ex311_8.htm EX-31.1 19181
3 EX-31.2 crsp-ex312_6.htm EX-31.2 19436
4 EX-32.1 crsp-ex321_7.htm EX-32.1 7722
  Complete submission text file 0001564590-20-019278.txt   5197473

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crsp-20200331.xsd EX-101.SCH 49545
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20200331_cal.xml EX-101.CAL 42268
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20200331_def.xml EX-101.DEF 136827
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20200331_lab.xml EX-101.LAB 369556
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20200331_pre.xml EX-101.PRE 263113
14 EXTRACTED XBRL INSTANCE DOCUMENT crsp-10q_20200331_htm.xml XML 761879
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 20825867
SIC: 2836 Biological Products, (No Diagnostic Substances)